Search

everythinglearnresearchcommunity

for

Search:↓

The CRH/CRH-R1 system might be involved in causing lichen planus.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Monitoring for adverse effects in clinical treatments is crucial.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Fat stem cells from diabetic mice can help heal skin wounds in other diabetic mice.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Various drugs caused different skin reactions, including allergic and inflammatory responses.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

SH-MSCs gel reduced IL-6 and increased TGF-β, suggesting it could treat alopecia.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.